Polyvagal-Informed Assessment: A Critical Review

Polyvagal-informed assessment refers to clinical evaluation methods that claim to measure or infer the functional state of the autonomic nervous system—particularly the vagus nerve and its purported role in social engagement, threat response, and physiological regulation—based on Stephen Porges's Polyvagal Theory. These assessments range from respiratory sinus arrhythmia (RSA) measurements, which quantify heart rate variability synchronized with breathing, to proprietary screening tools designed to identify "autonomic dysregulation" or readiness for interventions like the Safe and Sound Protocol (SSP). The appeal is straightforward: if the vagus nerve governs our capacity for safety, connection, and self-regulation, then measuring its activity should reveal who is struggling and why.

The reality is more complicated. While RSA is a legitimate physiological marker with decades of research behind it, its interpretation within a polyvagal framework involves theoretical leaps that remain contested. Many polyvagal-informed assessments are not validated against clinical outcomes, lack normative data, or conflate correlation with mechanism. Some are marketed directly to consumers or clinicians without peer-reviewed evidence of reliability or predictive validity. This does not mean they are useless—it means their evidentiary status must be understood clearly. In a field where nervous system language has become both popular and profitable, distinguishing between what is measured, what is inferred, and what is assumed is not optional.

The promise of polyvagal-informed assessment is seductive: a window into the nervous system's hidden logic, a way to see beneath behavior into biology. For clinicians working with trauma, anxiety, chronic pain, or developmental differences, the idea that a simple screen could reveal autonomic state—and guide intervention—offers both efficiency and legitimacy. For clients, it offers explanation. The nervous system becomes less mysterious, more mappable, more treatable.

But assessment tools do not exist in a vacuum. They shape clinical decision-making, insurance reimbursement, research design, and public understanding of what the nervous system is and does. When an assessment is presented as measuring "vagal tone" or "neuroception," it imports not just data but theory—and if that theory is incomplete, oversimplified, or misapplied, the assessment can mislead as much as it informs. This matters especially in populations already vulnerable to misdiagnosis or overtreatment: children with developmental trauma, autistic individuals, people with chronic illness, those navigating systemic marginalization.

The stakes are also financial. Polyvagal-informed tools are increasingly embedded in commercial ecosystems—training programs, certification pathways, proprietary software, therapeutic protocols. Some are evidence-based. Some are not. The line between clinical innovation and entrepreneurial opportunism is not always clear, and the burden of discernment falls unevenly on practitioners who may lack the time, training, or institutional support to evaluate claims critically.

This review is not a dismissal. RSA has robust empirical support as a marker of parasympathetic influence on the heart. Autonomic assessment has clinical value. But value depends on precision. We need to know what these tools actually measure, what they predict, and where the evidence ends and the interpretation begins. In a nervous-system-literate culture, that clarity is not pedantic—it is protective.

Respiratory sinus arrhythmia (RSA) is the most widely studied physiological marker associated with polyvagal-informed assessment. RSA reflects the rhythmic fluctuation in heart rate that occurs with breathing: heart rate increases during inhalation and decreases during exhalation, mediated primarily by the vagus nerve's myelinated efferent fibers to the sinoatrial node. Decades of research have established RSA as a noninvasive index of cardiac vagal control (Laborde et al., 2017). Higher resting RSA is generally associated with better emotion regulation, greater social engagement, and lower anxiety in both children and adults (Beauchaine & Thayer, 2015). Longitudinal studies have linked low RSA to increased risk for psychopathology, including depression and externalizing disorders (Koenig et al., 2016).

However, RSA is not a direct measure of "vagal tone" in the colloquial sense, nor does it map cleanly onto Porges's tripartite model of autonomic states (ventral vagal, sympathetic, dorsal vagal). RSA reflects parasympathetic influence on the heart, but it does not distinguish between different vagal pathways, nor does it measure the unmyelinated dorsal vagal complex that Porges associates with immobilization and shutdown. Critically, RSA is influenced by respiration rate, tidal volume, posture, medication, and metabolic state—factors that complicate interpretation in clinical settings (Grossman & Taylor, 2007). A low RSA may reflect poor vagal regulation, but it may also reflect shallow breathing, beta-blocker use, or simply a different constitutional baseline.

Polyvagal Theory posits that the ventral vagal complex supports social engagement and that its function can be inferred from RSA and other autonomic markers. Yet systematic reviews have found limited empirical support for the theory's core claims, particularly the phylogenetic and anatomical assertions about vagal pathways (Grossman, 2023). A 2022 consensus statement published in Biological Psychology concluded that while RSA is a valid measure of cardiac vagal activity, its use as a proxy for "neuroception" or "ventral vagal state" lacks direct empirical validation (Quintana et al., 2022). The theory's heuristic value in clinical practice does not automatically confer scientific validity to the assessments derived from it.

Beyond RSA, several proprietary tools have emerged. The Safe and Sound Protocol, developed by Porges and commercialized by Integrated Listening Systems, includes a pre-intervention screening process intended to assess readiness and predict response. However, no peer-reviewed studies have validated this screening tool against independent clinical outcomes. Similarly, various "autonomic assessment" questionnaires circulate in somatic and trauma therapy communities, often without published psychometric data. A 2023 review in Frontiers in Psychiatry noted that many polyvagal-informed clinical tools lack the reliability and validity testing required for evidence-based practice (Colvonen et al., 2023).

There are exceptions. Heart rate variability (HRV) more broadly—of which RSA is one component—has been extensively studied in cardiology, psychiatry, and psychophysiology. Meta-analyses confirm that reduced HRV is associated with increased mortality, cardiovascular disease, and psychiatric morbidity (Kemp et al., 2017). Biofeedback protocols targeting HRV have shown promise in anxiety, depression, and PTSD, though effect sizes are modest and mechanisms remain debated (Goessl et al., 2017). These findings support the clinical relevance of autonomic assessment, but they do not validate the specific theoretical architecture of Polyvagal Theory.

In sum: RSA is real, measurable, and clinically informative. Its interpretation through a polyvagal lens is theoretically motivated but not empirically settled. Proprietary polyvagal-informed assessments vary widely in rigor, and many have not been subjected to independent validation. Clinicians and researchers must distinguish between the measurement itself and the interpretive framework applied to it.

The Nervous System Intelligence framework begins with a different premise: the nervous system is not a ladder of evolutionary stages but a prediction engine, continuously generating models of safety, threat, and need based on past experience and present context. What Polyvagal Theory calls "neuroception"—the unconscious detection of safety or danger—NSI understands as predictive inference: the brain's best guess about what is happening and what to do next, updated moment by moment as new sensory data arrive.

This reframing has implications for assessment. If the nervous system is intelligent, then what we measure is not a fixed "state" but a dynamic process—a prediction in motion. RSA, heart rate variability, skin conductance, and other autonomic markers are not readouts of an underlying vagal "tone" but traces of the nervous system's ongoing adjustments: predictions about metabolic demand, social context, threat proximity, and resource availability. A low RSA in a given moment may reflect a prediction that energy conservation is needed, that the environment is unsafe, or that social engagement is costly. It does not reveal a broken system; it reveals a system doing what it was trained to do.

This distinction matters clinically. Polyvagal-informed assessment often frames autonomic patterns as deficits to be corrected—low vagal tone, poor regulation, stuck in sympathetic arousal. NSI assessment asks a different question: what prediction is this nervous system making, and why might that prediction have been adaptive? This is where the NIRVA Method's first two movements—Notice and Interrupt—become essential. Notice invites the client and clinician to observe autonomic patterns without pathologizing them. Interrupt creates space to question whether the prediction still serves.

Polyvagal-informed tools can be useful within this framework, but only if their limitations are acknowledged. RSA can help a client see that their nervous system is not imaginary or volitional—it is physiological, measurable, and responsive. But it cannot tell the whole story. A comprehensive NSI-informed assessment integrates autonomic data with context: developmental history, relational patterns, environmental stressors, cultural and systemic factors. It asks not just "What is your vagal tone?" but "What has your nervous system learned to predict, and under what conditions does that prediction shift?"

The NIRVA Method's later movements—Identify, Regulate, Validate, and Align—depend on this nuanced understanding. Identify asks what the prediction is protecting or pursuing. Regulate explores whether new inputs can update the prediction. Validate honors the intelligence of the original learning. Align asks whether the prediction now serves the life the person is trying to build. Polyvagal-informed assessment, used carefully, can support this process. Used carelessly, it risks reducing a person to a number.

For clinicians, the appeal of polyvagal-informed assessment is understandable. It offers a physiological anchor in a field often dominated by subjective report and diagnostic ambiguity. It provides clients with a tangible explanation for experiences that feel chaotic or shameful. It can guide intervention selection, track progress, and justify treatment to payers.

But clinical utility depends on epistemic humility. If you use RSA or HRV in your practice, know what you are measuring and what you are inferring. RSA reflects cardiac vagal influence, not "ventral vagal state." It is affected by respiration, posture, medication, and metabolic factors. Interpret it in context, not in isolation. Do not tell a client they have "low vagal tone" as if it were a diagnosis. Tell them their nervous system is showing signs of sustained activation or reduced flexibility, and explore with them what that might mean.

If you use proprietary polyvagal-informed screening tools—whether for SSP readiness, trauma assessment, or autonomic profiling—ask for the evidence. Has the tool been validated in peer-reviewed research? Are there normative data for the population you serve? What is the sensitivity and specificity? If the answers are unclear or unavailable, proceed with caution. Use the tool as one source of information, not the foundation of your formulation.

Be especially careful with language. Terms like "neuroception," "vagal brake," and "dorsal shutdown" are theoretical constructs, not established physiological entities. They can be useful metaphors, but they are not synonyms for observable biology. When you use them with clients, clarify that you are offering a model, not a fact. This is not splitting hairs—it is informed consent.

Finally, consider who benefits from the assessment. Does it empower the client, or does it pathologize? Does it open possibilities, or does it narrow them? Does it account for systemic and cultural context, or does it locate the problem solely within the individual's nervous system? Polyvagal-informed assessment, like any clinical tool, can be used in ways that are liberatory or reductive. The difference lies not in the tool itself but in the interpretive frame you bring to it.

Clinicians trained in the NIRVA Method will recognize this as an application of Validate and Align: honoring the intelligence of the nervous system while asking whether the current prediction serves the person's larger goals. Assessment is not neutral. It is an intervention, and it carries a message. Make sure the message is accurate.

If you are considering a polyvagal-informed assessment—whether offered by a therapist, a wellness program, or a direct-to-consumer platform—here is what to ask.

First: What is being measured? If the answer involves heart rate variability or RSA, that is a legitimate physiological marker. If the answer is vague—"autonomic state," "nervous system health," "vagal tone"—ask for specifics. What sensors are used? What data are collected? How are they analyzed?

Second: What does the result mean? A number or a graph is not self-explanatory. Ask how the result was interpreted, what it predicts, and what the evidence base is. If you are told you have "low vagal tone," ask what that means functionally, how it was determined, and whether other factors—like your breathing pattern, medication, or recent stress—were considered.

Third: What happens next? Is the assessment being used to guide a specific intervention, or is it an end in itself? If an intervention is recommended—such as the Safe and Sound Protocol, HRV biofeedback, or a somatic therapy—ask whether the assessment has been shown to predict response to that intervention. If the answer is no, the assessment may still be informative, but it is not a roadmap.

Fourth: How does this fit with what you already know about yourself? Your lived experience is data. If an assessment suggests your nervous system is "stuck in shutdown" but you feel energized and connected, trust the discrepancy. The assessment may be measuring something real, but it is not measuring everything. Context matters. Your history matters. Your current environment matters.

Finally: Remember that assessment is not diagnosis. A polyvagal-informed screen can offer insight, but it cannot tell you who you are or what you need. It is one lens among many. The nervous system is intelligent, adaptive, and context-dependent. Any tool that reduces it to a single score or state is, by definition, incomplete.

If you are working with a clinician who uses these tools, ask them to walk you through the interpretation. Ask what the assessment can and cannot tell you. Ask how it will inform your work together. A good clinician will welcome these questions. A great one will have already answered them.